ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978

Harvard’s Harvey Fineberg Is Elected IOM President.

November 16, 2001

Sole Source Negotiations

October 17, 1975

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture

February 25, 2011